Join us at the SOT’s 62nd Annual Meeting and ToxExpo, featuring world-class toxicology alongside networking and social opportunities. Toxys will be present on-site with a booth (#515) and we are looking forward to meeting you and answering all of your questions regarding our unique NAMs.

Toxys Workshop at SOT 2023 (ancillary meeting)

You are cordially invited to join the Toxys workshop and social event during the SOT 2023 meeting in Nashville. The workshop provides a unique opportunity to learn more about the unique in vitro assays for genotoxicity, developmental toxicity and mechanistic toxicity testing that Toxys offers. We will update you on the latest developments around ToxTracker, ReproTracker and ToxProfiler and its applications. We have invited a few users of our assays to share their experiences. You will get the opportunity to ask questions about the assays and meet up with your colleagues while enjoying a drink and snacks.

Presentations:

• Giel Hendriks, Toxys: Short overview and updates for ToxTracker, ReproTracker and ToxProfiler.
• Stephanie Kellum, Corteva Agriscience: ToxTracker: exploring early-stage screening of agricultural analogs.
• Thomas Steger-Hartmann, Bayer Pharmaceuticals: ITLF evaluation of the ToxProfiler assay for early safety assessment of pharmaceutical compounds.
• Heeteak Kang, LyondellBasell: Application of the ReproTracker assays for developmental toxicity assessment of chemicals.

When: 21 March at 5.00 – 7.00 pm
Where: Hilton Nashville Downtown – Room Bredesen (4th Ave S).

Exhibitor Hosted Session

You are also invited to join us at a speciality session that we will host together with the Institute for In Vitro Sciences (IIVS) on the regulatory acceptance of ToxTracker during the SOT 2023 meeting in Nashville.

In this session, we will: 

• Address the process and the typical timeline for emerging technologies to be accepted at the OECD
• Provide a unique opportunity to learn more about the ToxTracker reporter assay for cancer hazard assessment
• Update you on the latest developments around the validation study for ToxTracker
• Elaborate on the extended availability of ToxTracker and integration with the Good In Vitro Methods Practices (GIVMP) principles

Presenters

• Giel Hendriks, Toxys
• Hans Raabe, IIVS

When: 21 March 1.30 – 2.30
Where: Room 101D, Music City Centre

You can also meet us at our poster presentations:

• 20 March, 9.00 AM – 10.45 AM CDT: Teratogenicity Assessment of Antimalarials Early in Drug Development Using the ReproTracker Assay (with MMV) #P694
• 20 March, 10.45 AM – 12.30 PM CDT: Elucidating the Mode of Action of Genotoxic Substances Using a Combination of GFP Reporter Genes and Duplex Sequencing (with TwinStrand) #P361
• 21 March, 10.45 AM – 12.30 PM CDT: Update on the Ongoing OECD Validation of the ToxTracker Assay for Genotoxic Mode-of-Action Assessment #P355
• 22 March, 10.45 AM – 12.30 PM CDT: Toxicological Activity Profiling and Potency Ranking of Per‐ and Polyfluoroalkyl Substances (PFAS) Using ToxProfiler #P244

Find out more about our assays in the posters/sessions by others:

• 20 March, 9.00 AM – 10.45 AM CDT: Pilot Study on Human Pluripotent Cell Model for Assessing Developmental Toxicity of Fragrance Materials (by Research Institute for Fragrance Materials), P672
• 20 March, 10.45 AM – 12.30 PM CDT: ToxTracker and In Vitro Micronucleus: A Comparative Assessment (by Corteva), P352
• 20 March, 10.45 AM – 12.30 PM CDT: A feasibility study to evaluate genotoxicity of reference combustible and oral tobacco product using in vitro regulatory and mechanistic genotoxicity assays (By Altria Client Services LLC), P348
• Symposium Session Presentation, 20 March, 3.30 PM – 4.05 PM CDT: Using Toxicological Data for Sustainable Design of Flame Retardant Chemistry (by ICL IP)